Tissue Regenix Says Trading Remains In Line With Expectations

Fri, 16th Mar 2018 16:21

LONDON (Alliance News) - Tissue Regenix Group PLC, a regenerative medical devices company, said Friday that current trading remains in line with expectations and results for 2017 will now be released on March 26 due to an ongoing audit process.

"The board is satisfied that there are no negative issues and trading remains in line with board expectations," the company said in a short statement.

Shares in the company were trading 8.6% lower at 8.00 pence in afternoon trade.

Related Shares

More News

18 Apr 2024 14:12

UK shareholder meetings calendar - next 7 days

19 Mar 2024 14:24

Tissue Regenix annual loss narrows sharply as revenue jumps

(Alliance News) - Tissue Regenix Group PLC on Tuesday said it was aiming for longer-term growth as it reported a sharp reduction in its annual losses.

12 Mar 2024 14:29

UK earnings, trading statements calendar - next 7 days

6 Feb 2024 10:42

IN BRIEF: Tissue Regenix ships first allograft products order

Tissue Regenix Group PLC - Leeds, England-based medical devices - First order of its allograft products has been shipped from its third-party Irish lo...

25 Jan 2024 20:21

TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: